AARTI DRUGS
Back to Cashflow Statement
|
AARTI DRUGS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-136 Cr | ₹17 Cr | ₹92 Cr | ₹-81 Cr | ₹-215 Cr |
What is the latest Cash Flow from Financing Activities ratio of AARTI DRUGS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-136 Cr |
Mar2023 | ₹17 Cr |
Mar2022 | ₹92 Cr |
Mar2021 | ₹-81 Cr |
Mar2020 | ₹-215 Cr |
How is Cash Flow from Financing Activities of AARTI DRUGS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-136 Cr | Negative | |
Mar2023 | ₹17 Cr | -82.02 | |
Mar2022 | ₹92 Cr | Positive | |
Mar2021 | ₹-81 Cr | Negative | |
Mar2020 | ₹-215 Cr | - |
Compare Cash Flow from Financing Activities of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹3,858.8 Cr | -7.4% | -5.3% | -15.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | -7.4% |
-5.3% |
-15.6% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses